State of New Jersey Common Pension Fund D - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 109 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
State of New Jersey Common Pension Fund D ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$2,219,000
+1.6%
850,0000.0%0.01%0.0%
Q1 2019$2,185,000
+11.8%
850,0000.0%0.01%0.0%
Q4 2018$1,955,000
-28.4%
850,0000.0%0.01%
-20.0%
Q3 2018$2,729,000
+13.4%
850,0000.0%0.01%
+11.1%
Q2 2018$2,406,000
-20.0%
850,0000.0%0.01%
-25.0%
Q1 2018$3,009,000
-8.8%
850,0000.0%0.01%0.0%
Q4 2017$3,298,000
+52.8%
850,0000.0%0.01%
+33.3%
Q3 2017$2,159,000
-7.0%
850,0000.0%0.01%
-10.0%
Q2 2017$2,321,000
-17.5%
850,0000.0%0.01%
-16.7%
Q1 2017$2,814,000
+39.1%
850,0000.0%0.01%
+33.3%
Q4 2016$2,023,000
-35.2%
850,0000.0%0.01%
-30.8%
Q3 2016$3,120,000
+154.3%
850,000
+54.5%
0.01%
+116.7%
Q2 2016$1,227,000
+7.3%
550,0000.0%0.01%
+20.0%
Q1 2016$1,144,000
-65.7%
550,000
-50.0%
0.01%
-28.6%
Q4 2015$3,334,000
+145.3%
1,100,000
+100.0%
0.01%
+16.7%
Q3 2015$1,359,000550,0000.01%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
CM Management, LLC 1,500,000$1,620,0001.72%
Soleus Capital Management, L.P. 14,803,015$15,987,2561.48%
ARMISTICE CAPITAL, LLC 17,136,000$18,506,8800.28%
SPHERA FUNDS MANAGEMENT LTD. 1,228,126$1,326,3760.24%
GSA CAPITAL PARTNERS LLP 971,441$1,0490.09%
NJ State Employees Deferred Compensation Plan 200,000$216,0000.03%
Providence Wealth Advisors, LLC 27,500$29,0130.03%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 1,151,765$1,243,9060.03%
XTX Topco Ltd 164,238$177,3770.03%
JACOBS LEVY EQUITY MANAGEMENT, INC 3,369,076$3,638,6020.02%
View complete list of RIGEL PHARMACEUTICALS INC shareholders